知镜 Cognispect · 医学文献与研究工作台

Angiotensin receptor blocker ameliorates the development of tubulointerstitial injury and fibrosis associated with tubular proteinuria observed in subclinical diabetic kidney disease.

Campos MR, Seabra PHSR, Oliveira LBF, Lacerda VL, Souza TM, Moraes MC, Dos Santos LCC, Campos PP, Caruso-Neves C, Peruchetti DB.
Frontiers in pharmacology · 2026-08-20 · PMID 42694382

文献摘要

Introduction Subclinical Diabetic Kidney Disease ( sub DKD) is a clinically silent stage of kidney disease secondary to diabetes mellitus (DM), being a public health problem worldwide. The pathogenic mechanism involves hyperglycemia-induced tubulointerstitial injury associated with dysfunction of tubular protein reabsorption and proteinuria, even without any clinical signs like impaired glomerular function. Interestingly, angiotensin receptor blockers (ARBs), known as type 1 angiotensin II receptor (AT 1 R) antagonists, are effective against proteinuria in many kidney diseases, suggesting the potential involvement of the Renin-Angiotensin System. Herein, we studied the potential renoprotective effects of ARB on the pathogenesis of sub DKD. Methods For that, we developed streptozotocin (STZ)-induced type 1 DM [with normal levels of glomerular flow rate] in male Wistar rats, which were daily treated with 30 mg/kg/day losartan, a well-known ARB, via gavage for 6 consecutive weeks starting after induction of diabetes. Four experimental groups were generated: 1) CONT, normoglycemic rat; 2) ARB, normoglycemic rat treated with losartan; 3) sub DKD, diabetic rat; 4) sub DKD+ARB, diabetic rat treated with losartan. Results Comparing with the CONT group, the sub DKD group presented: 1) impaired tubular reabsorption of Na+ and Cl-; 2) proteinuria associated with dysfunction in cortical albumin endocytosis; 3) increased levels of urinary lactate dehydrogenase and γ-glutamyltransferase, markers of kidney and proximal tubule epithelial cell injuries, respectively; 4) increased kidney injury score and tubulointerstitial injury; 5) increased cortical type 1 collagen deposition. Interestingly, the ARB treatment ameliorated all parameters observed in diabetic rats ( sub DKD+ARB group). No significant changes were observed in the ARB group. Discussion Altogether, our findings indicated that ARB promotes renoprotective effects by attenuating AT1R-associated tubular damage and proteinuria of tubular origin observed in subDKD.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。